scholarly journals Colon perforation during percutaneous nephrolithotomy and fistula closure with Spongostan following conservative therapy

2015 ◽  
Vol 9 (5-6) ◽  
pp. 313 ◽  
Author(s):  
Sitki Ün ◽  
Volkan Çakır ◽  
Osman Köse ◽  
Hakan Türk ◽  
Yüksel Yılmaz
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Conservative Therapy ◽  
Left Kidney ◽  
Patient Comfort ◽  
Fistula Formation ◽  
Colon Perforation ◽  
Fistula Tract ◽  
External Drainage ◽  
Colonic Fistula

Percutaneous nephrolithotomy (PCNL) is the first-line treatment for kidney stones. Colon perforation is a rare, but dangerous, complication. Colonic perforation might be very serious if it is not found early. After an unsuccessful extracorporeal shockwave lithotripsy, a 45-year-old female underwent a left-sided PCNL for two 1-cm kidney stones in the left kidney upper pole calyx. During dilatation, a colon perforation was suspected. The procedure was finished by inserting a 14Fr re-entry catheter into the colon. On postoperative day 5, a fluoroscopy was performed by injecting contrast dye through the re-entry catheter, which showed a fistula formation between skin and colon. The catheter was removed completely. A 16Fr external drainage catheter was inserted over the guidewire through the fistula tract. The fistula was closed by introducing prepared absorbable hemostatic gelatin powder (Spongostan) particles into the fistula tract through the catheter. Fistula tracks can be closed early by injecting absorbable Spongostan particles into the colonic fistula tract, thereby reducing inpatient time and increasing patient comfort.

The Role of Tranexamic Acid in Controlling Bloodloss During PCNL for Staghorn Calculi

2019 ◽  
Vol 69 (12) ◽  
pp. 3745-3748
Author(s):  
Raluca Costina Barbilian ◽  
Victor Cauni ◽  
Bogdan Mihai ◽  
Ioana Buraga ◽  
Mihai Dragutescu ◽  
...  
Keyword(s):  
Blood Loss ◽  
Tranexamic Acid ◽  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Postoperative Bleeding ◽  
Invasive Technique ◽  
Transfusion Rate ◽  
Staghorn Calculi ◽  
Type Of Surgery

The aim of this paper is to assess the efficiency and safety of the tranexamic acid in reducing blood loss and the need for transfusion in patients diagnosed with staghorn calculi treated by percutaneous nephrolithotomy. Percutaneous nephrolithotomy (PCNL) is a minimally invasive technique used for large kidney stones. Hemorrhagic complications and urinary sepsis are serious complications associated with this type of surgery. Tranexamic acid is an antifibrinolytic drug that has the property of reducing intra or postoperative bleeding. The experience with tranexamic acid in preventing blood loss during percutaneous nephrolithotomy for is limited. The use tranexamic acid in percutaneous nephrolithotomy for staghorn type stones is safe and is associated with reduced blood loss and a lower transfusion rate.

The Control of Bloodloss During Percutanerous Nephrolithotomy Using Tranexamic Acid

2018 ◽  
Vol 69 (10) ◽  
pp. 2728-2730
Author(s):  
Raluca Costina Barbilian ◽  
Victor Cauni ◽  
Bogdan Mihai ◽  
Ioana Buraga ◽  
Mihai Dragutescu ◽  
...  
Keyword(s):  
Tranexamic Acid ◽  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Postoperative Bleeding ◽  
Invasive Technique ◽  
Transfusion Rate ◽  
Renal Lithiasis ◽  
Percutaneous Approach ◽  
Transfusion Requirements ◽  
Urinary Sepsis

The aim of this study is to assess the efficiency and safety of the tranexamic acid in reducing hemmorrhagic complications and transfusion requirements in patients with renal lithiasis treated by percutaneous approach. Percutaneous nephrolithotomy (PCNL) is a minimally invasive technique used for large kidney stones (]20mm). Urinary sepsis and intra or postoperative bleeding are the very serious complications associated with this type of procedure. Tranexamic acid is used in the treatment of many haemorrhagic conditions. The experience with tranexamic acid in preventing bloodloss during percutaneous nephrolithotomy is very limited. The use tranexamic acid in percutaneous nephrolithotomy is safe and is associated with reduced blood loss and a lower transfusion rate.

Spontaneous External Drainage of Renal Abscess through Persistent NephrostomyTract Eleven Years after Percutaneous Nephrolithotomy

2005 ◽  
Vol 75 (1) ◽  
pp. 88-90
Author(s):  
H. Suttmann ◽  
I. Kausch ◽  
C. Blietz ◽  
O. Walden ◽  
C. Doehn ◽  
...  
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Renal Abscess ◽  
External Drainage

scholarly journals An unusual presentation of colon perforation following percutaneous nephrolithotomy

2014 ◽  
Vol 8 (11-12) ◽  
pp. 862 ◽  
Author(s):  
Barbara Chubak ◽  
Joshua M Stern
Keyword(s):  
Sore Throat ◽  
Percutaneous Nephrolithotomy ◽  
Current Literature ◽  
Signs And Symptoms ◽  
Bowel Injury ◽  
Unusual Presentation ◽  
Diagnosis And Treatment ◽  
Colon Perforation ◽  
Tubeless Pcnl ◽  
Prompt Diagnosis

Colon perforation is a rare but serious complication of percutaneous nephrolithotomy (PCNL), meriting particular attention to its signs and symptoms for prompt diagnosis and treatment. We report an unusual presentation of colon perforation following tubeless PCNL, characterized by sore throat, pneumomediastinum, and neck and shoulder crepitus. In addition to the details of this case, we review the current literature on bowel injury during PCNL and its management.

Which Should be Preferred for Moderate-Size Kidney Stones? Ultramini Percutaneous Nephrolithotomy or Retrograde Intrarenal Surgery?

2016 ◽  
Vol 30 (12) ◽  
pp. 1285-1289 ◽  
Author(s):  
Arif Demirbas ◽  
Berkan Resorlu ◽  
Mehmet Melih Sunay ◽  
Tolga Karakan ◽  
Mehmet Ali Karagöz ◽  
...  
Keyword(s):  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Retrograde Intrarenal Surgery ◽  
Moderate Size

scholarly journals More Minimally Invasive Percutaneous Nephrolithotomy in Adult Patients with Kidney Stones

2021 ◽  
pp. 221-224
Author(s):  
Bülent KATI ◽  
Adem TUNÇEKİN ◽  
İbrahim Halil ALBAYRAK ◽  
Muhammed Nur KARADENİZ ◽  
Halil ÇİFTÇİ
Keyword(s):  
Minimally Invasive ◽  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Adult Patients ◽  
Minimally Invasive Percutaneous Nephrolithotomy

Comparison of Retrograde Intrarenal Surgery and Micro-Percutaneous Nephrolithotomy for Kidney Stones: A Meta-Analysis

2020 ◽  
pp. 1-7
Author(s):  
Zhenhua Gu ◽  
Yucheng Yang ◽  
Rui Ding ◽  
Meili Wang ◽  
Jianming Pu ◽  
...  
Keyword(s):  
Hospital Stay ◽  
Percutaneous Nephrolithotomy ◽  
Kidney Stones ◽  
Operative Time ◽  
Meta Analysis ◽  
Length Of Hospital Stay ◽  
Clinical Results ◽  
Retrograde Intrarenal Surgery ◽  
Alternative Approach ◽  
Significant Difference

<b><i>Background:</i></b> Advances in micro-percutaneous nephrolithotomy (PCNL) for kidney stones have made it an alternative approach to the retrograde intrarenal surgery (RIRS) approach. Nevertheless, the superiority of micro-PCNL over RIRS is still under debate. The results are controversial. <b><i>Objectives:</i></b> The purpose of this study was to systematically evaluate the clinical results in patients presenting with kidney stones treated with micro-PCNL or RIRS. <b><i>Methods:</i></b> A literature search was done for electronic databases to identify researches that compared micro-PCNL and RIRS till December 2019. The clinical outcome included complications, stone-free rates (SFRs), hemoglobin reduction, length of hospital stay, and operative time. <b><i>Results:</i></b> Five articles were included in our study. The pooled results revealed no statistical difference in the rate of complications (OR = 0.99, 95% CI = 0.57–1.74, <i>p</i> = 0.99), length of hospital stay (MD = −0.29, 95% CI = −0.82 to 0.24, <i>p</i> = 0.28), and operative time (MD = −6.63, 95% CI = −27.34 to 14.08, <i>p</i> = 0.53) between the 2 groups. However, significant difference was present in hemoglobin reduction (MD = −0.43, 95% CI = −0.55 to 0.30, <i>p</i> &#x3c; 0.001) and the SFRs (OR = 0.59, 95% CI = 0.36–0.98, <i>p</i> = 0.04) when comparing RIRS with micro-PCNL. <b><i>Conclusions:</i></b> Compared with micro-PCNL to treat kidney stones, RIRS is associated with better stone clearance and bearing higher hemoglobin loss. As the advantages of both technologies have been shown in some fields, the continuation of well-designed clinical trials may be necessary.

Sign in / Sign up

Export Citation Format

Share Document